|
Pipeline Blows: GSK, Medicines Co. Abandon Development of Drugs
GlaxoSmithKline (GSK) and Medicines Co. separately ended development of investigational drugs last week, with GSK pulling the plug on a complicated urinary tract infection (cUTI) treatment.
This article is viewable by subscribers only. To view this article, please select an option below.
|
|
Subscribe
Archives